Abstract:Abstract Background: Multiple clinical genome-wide analysis identified that chromosome 16p13.11 is a hotspot associated with neuropsychiatric disorders such as autism, schizophrenia and epilepsy. Nodal modulator 1 (NOMO1), located on human chromosome 16p13.11, was considered as a candidate gene with neuropsychiatric disorders. However, it is unknown whether the nomo1 deficiency causes neurological abnormalities, and the molecular mechanisms and pathogenesis of the NOMO1 gene remain unclear. To study the effects of nomo1 deficiency on brain development and neuropsychiatric system, a nomo1 knockout zebrafish model was established.Methods: We developed a viable vertebrate model of nomo1 loss-of-function using CRISPR/Cas9 technology and characterized nomo1 mutant zebrafish. Phenotypic and functional studies of developing nomo1 mutant zebrafish, including morphological measurements, behavioral assays, and functional mechanistic analyses, were performed.Results: Morphological differences in the phenotype of nomo1-/- zebrafish gradually became less noticeable during development, however, the enlarged interstitial spaces in midbrain and hindbrain were detected in nomo1 mutant zebrafish. Meanwhile, the nomo1 deficiency caused the change of expression levels in neurotransmitters of γ-aminobutyrate, glutamate and serotonin. Interestingly, the nomo1 loss-of-function zebrafish model exhibited social defects and repetitive behaviors in juvenile, which represented autism-like behaviors. The transcriptome analysis showed different gene expression patterns in mutant zebrafish at the genetic level. Further results revealed that the neuroactive drug PTZ recovered the decreased locomotor phenotype in larval mutant zebrafish.Conclusions: In this study, we established a nomo1 vertebrate animal model using CRISPR/Cas9 gene editing approach. The loss-of-function of nomo1 displayed autism-like behaviors and altered levels of the γ-aminobutyrate, glutamate and serotonin in zebrafish, which provide evidence that nomo1 as a candidate gene for autism. The versatility of zebrafish model is contributed to studying NOMO1-related disorders and conducting drug screening in future.Limitations: Further studies are needed to determine whether an intervention with a neuroactive drug in nomo1-/- zebrafish to alter the behavioral phenotype is applicable to the behavior of human patients.

Deficiency of nde1 in zebrafish induces brain inflammatory responses and autism-like behavior

Zebrafish Knockout of Frk Gene Shows Social Impairments Relevant to Autism and Delays Brain Development by Increasing Cell Proliferation

Alteration of the neuronal and glial cell profiles in Neu1-deficient zebrafish

Deficiency of DDX3X Results in Neurogenesis Defects and Abnormal Behaviors Via Dysfunction of the Notch Signaling

Nomo1 Deficiency Causes Autism-Like Behavior in Zebrafish.

Nde1 is required for heterochromatin compaction and stability in neocortical neurons

Loss of Zmiz1 in mice leads to impaired cortical development and autistic-like behaviors

Developmental Dopaminergic Signaling Modulates Neural Circuit Formation and Contributes to Autism Spectrum Disorder- Related Phenotypes

Zmiz1 is a novel regulator of brain development associated with autism and intellectual disability

Genetic and Environmental Factors Co-Contributing to Behavioral Abnormalities in adnp/adnp2 Mutant Zebrafish

Loss-of-function of the NOMO1 Gene Causes Neuropsychiatric Disorder-related Phenotypes

Impairments of cerebellar structure and function in a zebrafish KO of neuropsychiatric risk gene znf536

NEFLb Impairs Early Nervous System Development Via Regulation of Neuron Apoptosis in Zebrafish.

Deficiency of FRMD5 results in neurodevelopmental dysfunction and autistic-like behavior in mice

The scaffold protein Nde1 safeguards the brain genome during S phase of early neural progenitor differentiation

Genetic ablation of GIGYF1 , associated with autism, causes behavioral and neurodevelopmental defects in zebrafish and mice

Morphological, behavioral and molecular studies on CRISPR/Cas9-mediated knockout of the NOMO1 gene in zebrafish

Knockout of tanc2 causes autism‐like behavior and sleep disturbance in zebrafish

Social withdrawal and anxiety-like behavior have an impact on zebrafish adult neurogenesis

Genetic Ablation of<i> GIGYF1,</i> Associated With Autism, Causes Behavioral and Neurodevelopmental Defects in Zebrafish and Mice

kcnb1 loss-of-function in zebrafish causes neurodevelopmental and epileptic disorders associated with GABA dysregulation